Targeted EV to Deliver Chemotherapy to Treat Triple-Negative Breast Cancers

Triple-negative breast cancers (TNBCs) are heterogeneous and metastatic, and targeted therapy is highly needed for TNBC treatment. Recent studies showed that extracellular vesicles (EV) have great potential to deliver therapies to treat cancers. This study aimed to develop and evaluate a natural com...

Descripción completa

Detalles Bibliográficos
Autores principales: Si, Yingnan, Chen, Kai, Ngo, Hanh Giai, Guan, Jia Shiung, Totoro, Angela, Zhou, Zhuoxin, Kim, Seulhee, Kim, Taehyun, Zhou, Lufang, Liu, Xiaoguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781632/
https://www.ncbi.nlm.nih.gov/pubmed/35057042
http://dx.doi.org/10.3390/pharmaceutics14010146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781632/
https://www.ncbi.nlm.nih.gov/pubmed/35057042
http://dx.doi.org/10.3390/pharmaceutics14010146

Ejemplares similares